A critical issue for primary care practice: knowledge and attitudes of family physicians regarding levothyroxine use
Abstract
Keywords
References
- 1. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017; 390 (10101): 1550-62.
- 2. Benvenga S, Carlé A. Levothyroxine formulations: pharmacological and clinical implications of generic substitution. Adv Ther. 2019; 36(2): 59-71.
- 3. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010; 170 (22): 1996-2003.
- 4. Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we’ve been and where we’re going. Adv Ther. 2019; 36(2): 47-58.
- 5. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014; 24(12): 1670-1751.
- 6. Chakera AJ, Pearce SH, Vaidya B. Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther 2012; 6: 1-11.
- 7. Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009; 23(6): 781-92.
- 8. Gaitonde DY, Rowley KD, Sweeney LB. Hypothyroidism: an update. Am Fam Physician. 2012; 86(3): 244-51.
Details
Primary Language
English
Subjects
Health Care Administration, Health Services and Systems (Other)
Journal Section
Research Article
Authors
Şenay Koçakoğlu
*
0000-0002-4155-3109
Türkiye
Dursun Çadırcı
0000-0003-0969-382X
Türkiye
Mehmet Ali Eren
0000-0002-3588-2256
Türkiye
Publication Date
October 20, 2023
Submission Date
July 17, 2023
Acceptance Date
September 10, 2023
Published in Issue
Year 2023 Volume: 15 Number: 3
Cited By
Health information behavior during the life transition among people diagnosed with hypothyroidism
Journal of the Association for Information Science and Technology
https://doi.org/10.1002/asi.24986


